Septerna, Common Stock Stock Current Asset
SEPN Stock | 27.09 2.81 11.57% |
Septerna, Common Stock fundamentals help investors to digest information that contributes to Septerna, Common's financial success or failures. It also enables traders to predict the movement of Septerna, Stock. The fundamental analysis module provides a way to measure Septerna, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Septerna, Common stock.
As of the 24th of December 2024, Non Current Assets Total is likely to drop to about 12.3 M. In addition to that, Other Current Assets is likely to drop to about 148.4 K. Septerna, |
Septerna, Common Stock Company Current Asset Analysis
Septerna, Common's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Septerna, Current Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Septerna, Common is extremely important. It helps to project a fair market value of Septerna, Stock properly, considering its historical fundamentals such as Current Asset. Since Septerna, Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Septerna, Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Septerna, Common's interrelated accounts and indicators.
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition |
In accordance with the recently published financial statements, Septerna, Common Stock has a Current Asset of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
Septerna, Fundamentals
Total Debt | 169.24 M | ||||
Number Of Employees | 68 | ||||
Total Asset | 130.87 M | ||||
Retained Earnings | (46.58 M) | ||||
Working Capital | 105.76 M | ||||
Net Asset | 130.87 M |
About Septerna, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Septerna, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Septerna, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Septerna, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Septerna, Common
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Septerna, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Septerna, Common will appreciate offsetting losses from the drop in the long position's value.Moving against Septerna, Stock
0.41 | FRTX | Fresh Tracks Therapeutics | PairCorr |
0.4 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
0.31 | FBIOP | Fortress Biotech Pref | PairCorr |
The ability to find closely correlated positions to Septerna, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Septerna, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Septerna, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Septerna, Common Stock to buy it.
The correlation of Septerna, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Septerna, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Septerna, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Septerna, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Septerna, Common Piotroski F Score and Septerna, Common Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.